Nyxoah SA (NYXH) stock
NYXHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.81−0.05 (-6.25%)
Close on Nov 20, 2026Market cap $34.64MP/E –Yield –
Nyxoah operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Nyxoah's operating income for the twelve months ending Dec 31, 2022 was -€32.50M. For fiscal 2025 it was -€83.49M. The highest annual figure on record is -€11.22M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€83.49M | – |
| FY2024 | Dec 31, 2024 | -€58.81M | – |
| FY2023 | Dec 31, 2023 | -€45.10M | – |
| FY2022 | Dec 31, 2022 | -€32.50M | – |
| FY2021 | Dec 31, 2021 | -€26.24M | – |
| FY2020 | Dec 31, 2020 | -€11.22M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -€20.59M | – |
| Q2 FY2025 | Jun 30, 2025 | -€19.85M | – |
| Q2 FY2024 | Jun 30, 2024 | -€13.31M | – |
| Q2 FY2023 | Jun 30, 2023 | -€11.88M | – |
| Q4 FY2022 | Dec 31, 2022 | -€9.05M | – |
| Q3 FY2022 | Sep 30, 2022 | -€8.78M | – |
| Q2 FY2022 | Jun 30, 2022 | -€7.39M | – |
| Q4 FY2021 | Dec 31, 2021 | -€6.54M | – |
| Q3 FY2021 | Sep 30, 2021 | -€8.07M | – |
See a number that looks wrong?